Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomediq
Copenhagen, Denmark
- Ownership
- Private
- Development stage
- Other
01
Overview
Biomediq's quantitative imaging biomarkers for mammography, knee MRI, and brain MRI have been validated in peer-reviewed studies, integrated into commercial solutions (e.g., ScreenPoint Medical’s Transpara platform), and used in multiple international clinical collaborations[2][3].
- Therapeutic areas
- OncologyNeurologyImmunologyRheumatology
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Digital Health Medical Devices
02
Partnerships
NovartisErasmus Medical Center (Rotterdam University)University of California San FranciscoMayo ClinicNordic BioscienceCCBR-Synarc
Beyond the preview
Go deeper on Biomediq.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biomediq.